Search

Search or Filter



Results

showing 1-10 of 5528

Global Health Watch: US CDC layoffs, CIFF funding cuts to NGOs + call for streamlined global health architecture at World Health Summit

The US government shutdown escalated this week as the Administration laid off thousands of workers before chaotically retracting many of these notices. The UK-based Children’s Investment Fund Foundation (CIFF) abruptly cut all funding to US-based NGOs, and world leaders urged a streamlined global health system amid funding cuts.

October 2025


Long-Acting PrEP: Priority Slides

Slides with the current status and proposed priorities for long-acting PrEP products, regulatory approvals, planning & budgeting, delivery, and much more.

October 2025


Cabotegravir Implementation

Implementation studies completed, ongoing, or planned for cabotegravir as of October 2025.

Prevention Option:

October 2025


Dapivirine Vaginal Ring Implementation

Ongoing and planned implementation studies for the dapivirine vaginal ring as of October 2025.

Prevention Option:

October 2025


Cabotegravir Volume

Allocation of non-commercial cabotegravir for PrEP supply in low- and middle-income countries, 2023-2026, as of October 2025.

Prevention Option:

October 2025


Dapivirine Vaginal Ring Volume

DVR supply available to low- and middle-income countries as of October 2025.

Prevention Option:

October 2025


Cabotegravir Regulatory Approval

Regulatory approvals and those pending for cabotegravir as of October 2025.

Prevention Option:

October 2025


Dapivirine Vaginal Ring Regulatory Approval

Regulatory approvals, pending decisions, and appeals as of October 2025.

Prevention Option:

October 2025


PrEP Price Comparison

Comparing the annual price of oral TDF/FTC vs. the dapivirine vaginal ring and injectable cabotegravir.

Prevention Option:

October 2025


Lenacapavir Regulatory Approval

Regulatory approvals, pending decisions, and appeals as of October 2025.

Prevention Option:

October 2025


showing 1-10 of 5528